|
How many volunteers were present at the Congress? : |
400 |
|
Delegates from which countries presented in the congress? : |
Austria, UK, USA, Germany, Italy |
|
Were the delegates of any other organizations present in the congress? : |
Yes |
|
If yes, please write the names of the organizations in the box : |
RSC |
|
What were the responses to your talking points? Were specific questions or concerns raised? : |
|
|
If you met staff members, please list their full names & positions. : |
Beatrix Schenker |
|
Please inform us if there are any follow up actions we need to talk with the members of the congress : |
|
|
Your experiences about the travel processes(Providing ticket, accommodation,...) : |
Providing visa was very difficult. |
|
Please give a briefing of your own observations and outcomes of the congress: : |
Biotrans covers all aspects of biocatalysis with special focus on enzyme mediated cascade reactions, enzyme discovery, bioinformatics, systems bio(techno)logy, protein engineering by directed evolution and/or rational design, enzyme immobilization, process development and scale-up as well as manufacturing of chemical products using bio-catalysts.
This series of meetings has been initiated in 1993 in Graz, Austria, and since then evolved to a true European event organized biennially. The success of the previous BioTrans meetings held in various European countries is a confirmation of the growing significance and interest in biocatalysis and biotransformation. This conference will be the 13th in this series of meetings bridging biologists and chemists in academia and industry.
Vienna (A) 2015, Manchester (UK) 2013, Giardini Naxos (I) 2011, Bern (CH) 2009, Oviedo (ES) 2007, Delft (NL) 2005, Olomouc (CZ) 2003, Darmstadt (D) 2001, Giardini Naxos (I) 1999, La Grande Motte (F) 1997, Warwick (UK) 1995, Graz (A) 1993.
Systems Biocatalysis is a new approach consisting of organizing enzymes in vitro to generate an artificial metabolism for synthetic purposes. The strategy of this key new platform deals with the analysis of enzymatic systems in vivo, the development and discovery of new bio-catalysts, and their assembly in vitro into novel synthetic metabolic pathways. This network aims at the controllable construction of metabolic pathways for the efficient synthesis of valuable chemical products. Tasks involved are the discovery of new bio-catalyst, the optimization of their function, mutual compatibility and regulation, and the construction of a continuous flux for high efficiency. These tasks require research in various disciplines, as well as in molecular and engineering aspects of whole synthetic reaction sequences. |